Jo Vandervoort

5.1k citations

67 papers · 3.0k indexed · h-index 28

Impact in

Pharmaceutical Science top 0.2%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
Oncology top 2%
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Surgical Treatments

Papers in ⓘ

Pharmaceutical Science 21
- Advanced Drug Delivery Systems 18
- Drug Solubulity and Delivery Systems 8
Oncology 18
- Pancreatic and Hepatic Oncology Research 9
- Colorectal Cancer Surgical Treatments 7

Co-authors: A. Ludwig (9 shared papers)Andreas Ludwig (13 shared papers)Kathleen Dillen (7 shared papers)David R. Lichtenstein (15 shared papers)Henry Montes (9 shared papers)Roy Soetikno (8 shared papers)Tony Tham (15 shared papers)Jacques Van Dam (12 shared papers)
Journals: Gastrointestinal Endoscopy (26 papers)International Journal of Pharmaceutics (6 papers)European Journal of Pharmaceutics and Biopharmaceutics (3 papers)Journal of Crohn s and Colitis (3 papers)Endoscopy (3 papers)
Partner nations: Belgium United States Denmark

In The Last Decade

Jo Vandervoort

66 papers receiving 2.9k citations

Peers

Countries citing papers authored by Jo Vandervoort

Since Specialization

Citations

This map shows the geographic impact of Jo Vandervoort's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jo Vandervoort with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jo Vandervoort more than expected).

Fields of papers citing papers by Jo Vandervoort

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jo Vandervoort. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jo Vandervoort. The network helps show where Jo Vandervoort may publish in the future.

Co-authors

The 25 scholars most cited alongside Jo Vandervoort, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jo Vandervoort Line = papers co-authored together Jo Vandervoort links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Risk factors for complications after performance of ERCP Gastrointestinal Endoscopy ·Jo Vandervoort, Roy Soetikno, Tony Tham, Richard C.K. Wong, Ângelo Paulo Ferrari, Henry Montes, Alfred Roston, Adam Slivka, David R. Lichtenstein, F. Ruymann, Jacques Van Dam, Mike Hughes, David L. Carr‐Locke	2002	442
2	Biocompatible stabilizers in the preparation of PLGA nanoparticles: a factorial design study International Journal of Pharmaceutics ·Jo Vandervoort, A. Ludwig	2002	191
3	Evaluation of ciprofloxacin-loaded Eudragit® RS100 or RL100/PLGA nanoparticles International Journal of Pharmaceutics ·Kathleen Dillen, Jo Vandervoort, Guy Van den Mooter, Andreas Ludwig	2006	187
4	Preparation and evaluation of drug-loaded gelatin nanoparticles for topical ophthalmic use European Journal of Pharmaceutics and Biopharmaceutics ·Jo Vandervoort, A. Ludwig	2003	184
5	Self-expandable metal stents for obstructing colonic and extracolonic cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Update 2020 Endoscopy ·Jeanin E. van Hooft, Joyce Veld, Dirk Arnold, Regina G. H. Beets‐Tan, Simon Everett, Martín Götz, Emo E. van Halsema, James Hill, Gianpiero Manes, Søren Meisner, Eduardo Rodrigues‐Pinto, Charles Sabbagh, Jo Vandervoort, Pieter J. Tanis, Geoffroy Vanbiervliet, Alberto Arezzo	2020	164
6	Development and characterization of Cyclosporine A loaded nanoparticles for ocular drug delivery: Cellular toxicity, uptake, and kinetic studies Journal of Controlled Release ·Pelin Aksungur, Murat Demirbilek, Emir Baki Denkbaş, Jo Vandervoort, Andreas Ludwig, Nurşen Ünlü	2011	144
7	Factorial design, physicochemical characterisation and activity of ciprofloxacin-PLGA nanoparticles International Journal of Pharmaceutics ·Kathleen Dillen, Jo Vandervoort, Guy Van den Mooter, Loes Verheyden, Andreas Ludwig	2004	143
8	Risk factors for complications after performance of ERCP Gastrointestinal Endoscopy ·Jo Vandervoort, Roy Soetikno, Tony Tham, Richard C.K. Wong, Ângelo Paulo Ferrari, Henry Montes, Alfred Roston, Adam Slivka, David R. Lichtenstein, F. Ruymann, Jacques Van Dam, Michael Hughes, David L. Carr‐Locke	2002	118
9	Accuracy and complication rate of brush cytology from bile duct versus pancreatic duct Gastrointestinal Endoscopy ·Jo Vandervoort, Roy Soetikno, Henry Montes, David R. Lichtenstein, Jacques Van Dam, F. Ruymann, Edmund S. Cibas, David L. Carr‐Locke	1999	114
10	Palliation of malignant gastric outlet obstruction using an endoscopically placed Wallstent Gastrointestinal Endoscopy ·Roy Soetikno, David R. Lichtenstein, Jo Vandervoort, Richard C.K. Wong, Alfred Roston, Adam Slivka, Henry Montes, David L. Carr-Locke	1998	84
11	Self-expandable metal stents for relieving malignant colorectal obstruction: short-term safety and efficacy within 30 days of stent procedure in 447 patients Gastrointestinal Endoscopy ·Søren Meisner, Ferrán Gónzalez‐Huix, Jo Vandervoort, Paul Goldberg, Juan Antonio Casellas, Óscar Roncero, Karl E. Grund, Alberto Álvarez, Jesús García-Cano, Enrique Vázquez-Astray, Javier Jiménez-Pérez	2011	83
12	The effect of freeze-drying with different cryoprotectants and gamma-irradiation sterilization on the characteristics of ciprofloxacin HCl-loaded poly(D,L-lactide-glycolide) nanoparticles Journal of Pharmacy and Pharmacology ·(unknown), Kathleen Dillen, Jo Vandervoort, A. Ludwig	2005	83
13	Cytotoxicity of submicron emulsions and solid lipid nanoparticles for dermal application International Journal of Pharmaceutics ·Wim Weyenberg, Plamen Filev, Dave Van den Plas, Jo Vandervoort, Kris De Smet, Philippe Sollie, Andreas Ludwig	2007	82
14	Colonic Stenting as a Bridge to Surgery in Malignant Large-Bowel Obstruction: A Report from Two Large Multinational Registries The American Journal of Gastroenterology ·Javier Jiménez-Pérez, Juan Antonio Casellas, Jesús García-Cano, Jo Vandervoort, Roncero O García-Escribano, José María Barcenilla, Álvarez A Delgado, Paul Goldberg, Ferrán Gónzalez‐Huix, Enrique Vázquez-Astray, Søren Meisner	2011	79
15	Safety of ERCP during pregnancy The American Journal of Gastroenterology ·Tony Tham, Jo Vandervoort, Richard C.K. Wong, Henry Montes, Alfred Roston, Adam Slivka, Ângelo Paulo Ferrari, David R. Lichtenstein, Jacques Van Dam, Richard D. Nawfel, Roy Soetikno, David L. Carr‐Locke	2003	78
16	Role of endoscopic retrograde cholangiopancreatography for suspected choledocholithiasis in patients undergoing laparoscopic cholecystectomy Gastrointestinal Endoscopy ·Tony Tham, David R. Lichtenstein, Jo Vandervoort, Richard C.K. Wong, David J. Brooks, Jacques Van Dam, F. Ruymann, Francis A. Farraye, D L Carr-Locke	1998	73
17	Ocular Drug Delivery: Nanomedicine Applications Nanomedicine ·Jo Vandervoort, Andreas Ludwig	2007	70
18	Management of occluded biliary Wallstents Gut ·Tony Tham, David L. Carr‐Locke, Jo Vandervoort, Richard C.K. Wong, David R. Lichtenstein, Jacques Van Dam, F. Ruymann, Simon C. Chow, John J. Bosco, T. Qaseem, Simon Howell, Douglas K. Pleskow, W Vannerman, Eric Libby	1998	69
19	Bedside Scoring System to Predict the Risk of Developing Pancreatitis Following ERCP Endoscopy ·Shai Friedland, Roy Soetikno, Jo Vandervoort, Henry Montes, Tony Tham, D Carr-Locke	2002	67
20	Adhesion of PLGA or Eudragit®/PLGA nanoparticles to Staphylococcus and Pseudomonas International Journal of Pharmaceutics ·Kathleen Dillen, Chris H. Bridts, Pieter Van der Veken, Paul Cos, Jo Vandervoort, Koen Augustyns, W. J. Stevens, Andreas Ludwig	2007	52

About Jo Vandervoort

Jo Vandervoort is a scholar working on Pharmaceutical Science, Oncology, Surgery, Biomaterials and Pulmonary and Respiratory Medicine, having authored 67 papers that have together received 3.0k indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (18 papers), Gallbladder and Bile Duct Disorders (16 papers), Pediatric Hepatobiliary Diseases and Treatments (12 papers), Esophageal and GI Pathology (10 papers), Pancreatic and Hepatic Oncology Research (9 papers), Drug Solubulity and Delivery Systems (8 papers), Colorectal Cancer Surgical Treatments (7 papers) and Nanoparticle-Based Drug Delivery (6 papers). The work is most often cited by research in Pharmaceutical Science (867 citations), Oncology (1.0k citations), Biomaterials (486 citations), Pulmonary and Respiratory Medicine (1.2k citations) and Surgery (1.5k citations). Jo Vandervoort has collaborated with scholars based in Belgium, United States and Denmark. Frequent co-authors include A. Ludwig, Andreas Ludwig, Kathleen Dillen, David R. Lichtenstein, Henry Montes, Roy Soetikno, Tony Tham, Jacques Van Dam, David L. Carr‐Locke and Guy Van den Mooter. Their work appears in journals such as Gastrointestinal Endoscopy, International Journal of Pharmaceutics, European Journal of Pharmaceutics and Biopharmaceutics, Journal of Crohn s and Colitis and Endoscopy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact